<DOC>
	<DOCNO>NCT00564590</DOCNO>
	<brief_summary>We hypothesize melatonin compare PPI placebo , improve GERD symptom decrease esophageal acid exposure esophageal acid sensitivity GERD . We hypothesize melatonin compare PPI placebo reduce frequency duration transient low esophageal sphincter relaxation ( TLESRs ) . In addition hypothesize melatonin compare PPI placebo improve quality life quality sleep GERD patient .</brief_summary>
	<brief_title>SThe Effects Melatonin GERD Symptoms</brief_title>
	<detailed_description>Background : Gastroesophageal reflux disease ( GERD ) chronic , persistent common medical problem . The standard care GERD include chronic administration acid-suppressive drug . However , clinical failure GERD increasingly report . Aim : To determine efficacy treatment melatonin compare standard dose proton pump inhibitor ( PPI ) compare placebo patient GERD . Study objective : [ 1 ] To compare degree GERD symptom improvement esophageal acid sensitivity treatment . [ 2 ] To determine effect treatment % total , upright supine time pH &lt; 4 use 24-hour esophageal pH monitoring . [ 3 ] To determine effect treatment frequency duration lower esophageal sphincter relaxation . [ 4 ] To compare quality life quality sleep GERD patient treatment . Methods : This randomize , double blind , parallel group study 150 patient GERD . Patients classic heartburn symptom ( heartburn and/or regurgitation ) normal upper endoscopy gastroenterology department Rabin Medical Center enrol study . At baseline , enrol patient 24-hour esophageal pH monitoring modify acid perfusion test ass extent distal esophageal acid exposure esophageal acid sensitivity , respectively . Patients evaluate demographic questionnaire , GERD Symptom Questionnaire , Quality Sleep questionnaire SF-36 . Baseline urinary excretion main melatonin metabolite , 6-sulfatoxymelatonin ( 6SMT ) assess subject baseline . Patients randomize either melatonin standard dose PPI placebo period 4 week . In addition patient fill diary daily basis document severity frequency GERD-related symptom . Symptom score ( frequency x severity ) calculate previous 7 day baseline end treatment group . After 4 week treatment , patient undergo second 24-hour esophageal pH monitoring , modify acid perfusion test complete GERD Symptom Questionnaire , Quality Sleep Questionnaire SF-36 . Implications : This study determine melatonin decrease GERD symptom , acid esophageal exposure improve quality life sleep patient GERD . Furthermore , significant clinical response melatonin possible add compound treatment armamentum GERD .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>INCLUSION CRITERIA : Ages 1875 . Male female . GERD symptoms least twice week last three month . Able read , understand complete study questionnaire diary Understand study procedure sign write informed consent . Able comply study requirement . EXCLUSION CRITERIA : Subjects erosive esophagitis ( EE ) , Barrett 's esophagus ( BE ) esophageal stricture adenocarcinoma upper endoscopy . Subjects previous upper gastrointestinal surgery . Subjects clinically significant medical condition ( cardiovascular , respiratory , renal , hepatic , hematologic , endocrine , neurologic psychiatric ) ; examples follow : liver cirrhosis , severe COPD , severe renal failure , severe heart failure , active malignancy . Subjects require narcotic ( morphine , methadone , etc. ) . Subjects require melatonin Subjects diabetes , scleroderma neuromuscular disorder . Lactating pregnant woman . Subjects unrecognized lifestyle shift worker .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>